Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Green Hits Milestone in Algae-Modification Initiative

Premium

Rosetta Green last week announced that it has successfully completed an experiment producing biologically active human growth hormone from algae.

The work was conducted as part of a collaborative effort funded by the European Commission focused on the use of genetic modifications to improve algae for industrial applications (GSN 7/28/2011).

Through the initiative, Rosetta Green is identifying miRNAs that could be used to develop algae that can produce therapeutic human proteins and growth hormone.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.